Teva Pharmaceutical Industries Limited (TEVA) Announces Positive Results from a Study Assessing a New Formulation of Copaxone(R)  
6/4/2010 11:07:36 AM

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced positive results from a study assessing a new lower-volume injection of Copaxone® (glatiramer acetate) containing the currently approved dose in half the injection volume.